Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18432612 | 0.80 | KMT2A (0.46) | LCKFYNMAPTHPGDALDH1A1 | |
| SCHEMBL3327663 | 0.77 | ATM (0.37) | MAPTHPGDALDH1A1NPC1RAB9A | |
| SCHEMBL29280622 | 0.74 | NPC1 (0.49) | MAPTHPGDALDH1A1NPC1RAB9A | |
| SCHEMBL22916677 | 0.74 | MAPT (0.41) | MAPTALDH1A1NPC1RAB9AHSD17B10 | |
| SCHEMBL29280613 | 0.73 | CES2 (0.44) | LCKFYNMAPTALDH1A1NPC1 | |
| SCHEMBL29280610 | 0.73 | CES2 (0.44) | ALDH1A1NPC1RAB9ACES2CES1 | |
| SCHEMBL3958112 | 0.73 | LCK (0.55) | LCKFYNHPGDALDH1A1HSD17B10 | |
| SCHEMBL18015341 | 0.73 | SMN1; SMN2 (0.43) | LCKFYNNPC1RAB9AHSD17B10 | |
| SCHEMBL8214376 | 0.71 | RAB9A (0.46) | MAPTHPGDALDH1A1NPC1RAB9A | |
| SCHEMBL18420521 | 0.71 | NOTUM (0.45) | MAPTHPGDALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778551-A1 | ALKYNE COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210022338-A1 | ALKYNE COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-01-28 | — | — | US | disclosed |
| WO-2019189287-A1 | ALKYNE COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210022338-A1 | ALKYNE COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | C5, C9, C3AR1 | LCK 4227/4885FYN 3570/4885MAPT 4184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.